Tender Closed
|
|
RFx ID : | 24644645 |
Tender Name : | Future Procurement Opportunity (FPO) - Supply of Trastuzumab |
Reference # : | A1436422 |
Open Date : | Q3 2021 |
Indicative RFx Release Date : | Q3 2022 [?] |
Tender Type : | Future Procurement Opportunity (FPO) |
Project Status : | Initial development [?] |
Indicative Total Value : | $100M + [?] |
Expected number of contracts offered : | 1 |
Tender Coverage : | Sole Agency [?] |
Categories : |
|
Regions: |
|
Required Pre-qualifications : | None |
Contact : |
Pharmac Procurement Team procurement@pharmac.govt.nz |
Agency Address : | |
Related Tenders: |
Pharmac is planning on issuing a competitive process for supply of trastuzumab.
The approximate gross annual expenditure of trastuzumab in the 2020 FYR was $35,000,000. Information related to the listing of trastuzumab on the Pharmaceutical Schedule, including current funding restrictions is available on the PHARMAC website.
This tender has been completed.
Date RFx was completed/updated:
Monday, 13 February 2023 10:33 AM (Pacific/Auckland UTC+13:00)